265 related articles for article (PubMed ID: 23990668)
1. Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration.
Evensen NA; Kuscu C; Nguyen HL; Zarrabi K; Dufour A; Kadam P; Hu YJ; Pulkoski-Gross A; Bahou WF; Zucker S; Cao J
J Natl Cancer Inst; 2013 Sep; 105(18):1402-16. PubMed ID: 23990668
[TBL] [Abstract][Full Text] [Related]
2. The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.
Wang L; Yu T; Li W; Li M; Zuo Q; Zou Q; Xiao B
Oncogene; 2019 Apr; 38(17):3134-3150. PubMed ID: 30626935
[TBL] [Abstract][Full Text] [Related]
3. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
4. Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.
Jami MS; Hou J; Liu M; Varney ML; Hassan H; Dong J; Geng L; Wang J; Yu F; Huang X; Peng H; Fu K; Li Y; Singh RK; Ding SJ
BMC Cancer; 2014 Mar; 14():194. PubMed ID: 24628760
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
7. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).
Jiao X; Ye J; Wang X; Yin X; Zhang G; Cheng X
Med Sci Monit; 2019 Sep; 25():6788-6796. PubMed ID: 31501407
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of KIAA1199 in cancer development and therapy.
Liu J; Yan W; Han P; Tian D
Biomed Pharmacother; 2021 Jun; 138():111507. PubMed ID: 33773462
[TBL] [Abstract][Full Text] [Related]
9. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT.
Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J
J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628
[TBL] [Abstract][Full Text] [Related]
10. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
[TBL] [Abstract][Full Text] [Related]
11. Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells.
Birkenkamp-Demtroder K; Maghnouj A; Mansilla F; Thorsen K; Andersen CL; Øster B; Hahn S; Ørntoft TF
Br J Cancer; 2011 Aug; 105(4):552-61. PubMed ID: 21772334
[TBL] [Abstract][Full Text] [Related]
12. KIAA1199 and its biological role in human cancer and cancer cells (review).
Zhang Y; Jia S; Jiang WG
Oncol Rep; 2014 Apr; 31(4):1503-8. PubMed ID: 24573670
[TBL] [Abstract][Full Text] [Related]
13. KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
Zhao L; Zhang D; Shen Q; Jin M; Lin Z; Ma H; Huang S; Zhou P; Wu G; Zhang T
Oncogene; 2019 Feb; 38(7):935-949. PubMed ID: 30202098
[TBL] [Abstract][Full Text] [Related]
14. KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program.
Xu Y; Xu H; Li M; Wu H; Guo Y; Chen J; Shan J; Chen X; Shen J; Ma Q; Liu J; Wang M; Zhao W; Hong J; Qi Y; Yao C; Zhang Q; Yang Z; Qian C; Li J
Cancer Lett; 2019 Jul; 454():78-89. PubMed ID: 30980868
[TBL] [Abstract][Full Text] [Related]
15. KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
Kohi S; Sato N; Koga A; Matayoshi N; Hirata K
Oncotarget; 2017 Mar; 8(10):17156-17163. PubMed ID: 28179576
[TBL] [Abstract][Full Text] [Related]
16. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
[TBL] [Abstract][Full Text] [Related]
17. Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors.
Tiwari A; Schneider M; Fiorino A; Haider R; Okoniewski MJ; Roschitzki B; Uzozie A; Menigatti M; Jiricny J; Marra G
PLoS One; 2013; 8(7):e69473. PubMed ID: 23936024
[TBL] [Abstract][Full Text] [Related]
18. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
19. KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.
Terashima M; Fujita Y; Togashi Y; Sakai K; De Velasco MA; Tomida S; Nishio K
Oncotarget; 2014 Aug; 5(16):7040-50. PubMed ID: 25051373
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP).
Evensen NA; Li Y; Kuscu C; Liu J; Cathcart J; Banach A; Zhang Q; Li E; Joshi S; Yang J; Denoya PI; Pastorekova S; Zucker S; Shroyer KR; Cao J
Oncotarget; 2015 Aug; 6(24):20723-39. PubMed ID: 26009875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
